While artificial intelligence (AI) is helping clinicians in medical dermatology improve diagnostic accuracy, streamline ...

U.S. Dermatology Partners is pleased to announce that 90 Board-Certified Dermatologists have been named 2025 Top Doctors by ...

The risk for acne relapse following isotretinoin use is reduced with higher cumulative doses, suggesting individualized ...

Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

The key processes of skin aging are now being understood in sufficient detail that targeted prescription therapies for ...

CINCINNATI (WKRC) — As winter temperatures drop, local dermatologists warn that the cold weather can take a toll on your skin ...

Kimberly Werner Billet, MD, FAAD, is a board-certified dermatologist operating Dr. Kim Dermatology. She answers questions ...

SGX301 has led positive results in early-stage CTCL, with over 70% achieving treatment success in the phase 3 FLASH study.

For diverse patient populations who are historically marginalized within health care, student-run clinics may offer a ...

Everyday wear and tear and changes in the weather (cold or hot) could mean your feet need a little extra TLC,—that’s when you ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare ...